P. Hennart
Université libre de Bruxelles
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by P. Hennart.
European Journal of Clinical Nutrition | 2001
P. Donnen; Michèle Dramaix; D. Brasseur; R Bitwe; G Bisimwa; P. Hennart
Objective: To assess the usefulness of the molar ratio of serum retinol-binding protein (RBP) to transthyretin (TTR) to determine vitamin A (VA) status during infection.Design: We took advantage of previously collected data during a randomised double-blind, placebo-controlled clinical trial to conduct a secondary analysis of the RBP/TTR ratio and its relationship to infection and VA status. In this clinical trial, children were randomly assigned to one of three groups and received either one single oral high dose of VA (200 000 IU) on the day of admission and subsequently a placebo daily until discharge or daily oral low doses of VA (5000 IU) from admission until discharge or a placebo daily from admission until discharge.Setting: Lwiro pediatric hospital, Province of South Kivu, Democratic Republic of Congo.Subjects: A total of 900 children aged 0–72 months hospitalised consecutively between March 1994 and March 1996.Main outcome measures: RBP/TTR molar ratio after 7 days hospitalisation.Results: After 7 days hospitalisation, molar RBP:TTR ratio (mean±s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67±0.31 in the high-dose group (n=81), 0.74±0.44 in the low dose group (n=71) and 0.73±0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 µmol/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548).Conclusions: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection.Sponsorship: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Médicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.European Journal of Clinical Nutrition (2001) 55, 1043–1047
Revue D Epidemiologie Et De Sante Publique | 2004
Victoire Agueh; Michel Makoutodé; M. Dramaix; Bruno Dujardin; P. Hennart
BACKGROUND This study aimed to assess the effectiveness of a protein-energetic malnutrition prevention and treatment community program on the nutritional status of 18 to 36-month-old children in the poor communities of the Mono Region in Benin. METHODS Two cross sectional anthropometric surveys were conducted. The first survey took place in 1998, before the implementation of the program; the second survey was conducted three years later. At each survey, cluster samples proportional to the population size was done; the sizes of the samples were 617 in 1998 and 648 in 2001. The nutritional status of 18 to 36 month-old-children was assessed by z-score of the indexes height-for-age, weight-for-age and weight-for-height and the cut-off point of -2 standard deviation was used to identify children who had stunting, wasting or underweight; children with serious stunting, wasting or underweight were identified with the cut-off point of -3 standard deviation. RESULTS From 1998 to 2001, there was a significant reduction in the prevalence of growth retardation (-13.1%) and underweight (-13.0%). The reductions observed for the three types of protein-energetic malnutrition were more pronounced in the 30 to 36 months age group than in the others age groups. CONCLUSION Substantial improvement was observed during the three years activities. This improvement cannot be attributed to the program unconditionally, because there was no difference between the nutritional status of participant and non participant children.
Revue D Epidemiologie Et De Sante Publique | 2007
Léon G. Blaise Savadogo; I. Zoetaba; Philippe Donnen; P. Hennart; Blaise Sondo; M. Dramaix
Revue D Epidemiologie Et De Sante Publique | 2002
Léon G. Blaise Savadogo; Hamadé Ouédraogo; M. Dramaix; A. Sawadogo; Blaise Sondo; R. Tonglet; Philippe Donnen; P. Hennart
Revue D Epidemiologie Et De Sante Publique | 2008
M. Halidou Doudou; H. Degbey; H. Daouda; Alain Levêque; Philippe Donnen; P. Hennart; Michèle Dramaix-Wilmet
Tropical Medicine & International Health | 1997
Ph. Donnen; D. Brasseur; Michèle Dramaix; V. Assimbo; P. Hennart
Revue D Epidemiologie Et De Sante Publique | 2007
Victoire Agueh; Michel Makoutodé; Moussiliou Noël Paraïso; M. Dramaix; Bruno Dujardin; P. Hennart
Revue D Epidemiologie Et De Sante Publique | 2007
Léon G. Blaise Savadogo; I. Zoetaba; P. Donnen; P. Hennart; Blaise Sondo; Michèle Dramaix
Revue D Epidemiologie Et De Sante Publique | 1993
M. Dramaix; P. Hennart; Paluku; Mudjene O; Smets R; Philippe Donnen; René Tonglet; Daniel Brasseur